President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...

Trump previously floated a 25% tariff on all imported drugs, though they were unaffected by recent reciprocal levies.

Analysts said tariffs would send prescription drug prices higher. Generic drugs and ingredients that are largely made ...

Indian pharmaceutical stocks tumbled 4.4% on Friday, erasing gains from the previous session, after Trump threatened steep ...

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

For some Big Pharma companies, sales in China contributed to more than 10 percent of global sales, making China a top market ...

Australia’s biggest healthcare companies, from global blood plasma giant CSL and surgical gloves supplier Ansell to sleep ...

Some of the country's largest drugmakers could be impacted by President Donald Trump's reciprocal tariffs, announced on ...

Evolving regulations in sterile manufacturing requires innovation, market knowledge, and investment. How can drug ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

Drugmakers are pushing back against pharmaceutical tariffs. Some companies are lobbying the Trump administration to phase in ...

For more than three decades, the pharmaceutical sector has been protected from tariffs by a World Trade Organization ...